The Protecting Patients from Deceptive Drug Ads Act aims to regulate communications about prescription drugs on social media.
The Protecting Patients from Deceptive Drug Ads Act amends the Federal Food, Drug, and Cosmetic Act to regulate communications about prescription drugs on social media. It imposes civil penalties on social media influencers and health care providers who make false or misleading statements about drugs. The bill also mandates the Secretary of Health and Human Services to issue guidance on these regulations, update relevant regulations, and conduct market surveillance activities.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.